Advanced Dopamine and Norepinephrine Reuptake Formula
This formula is designed to enhance cognitive function and repair areas of the brain damaged by technology overuse or substance abuse, particularly targeting the prefrontal cortex (PFC). The following compounds have been selected for their synergistic effects on dopamine and norepinephrine reuptake, neuroprotection, and cognitive enhancement.
Components:
DNSP-11 (Dopamine Neuron Stimulating Peptide)
Dosage: 10 mg subcutaneously, twice a week.
Function: Promotes the survival of dopamine neurons and enhances their function.
Tesofensine
Dosage: 0.5 mg orally, daily.
Function: A potent inhibitor of dopamine, norepinephrine, and serotonin reuptake, leading to increased concentrations of these neurotransmitters in the brain.
P5P (Pyridoxal-5-Phosphate)
Dosage: 100 mg orally, daily.
Function: The active form of Vitamin B6, which is a cofactor in the synthesis of dopamine and serotonin.
NA-Semax (N-Acetyl Semax)
Dosage: 300 mcg intranasally, twice a day.
Function: Enhances neurogenesis and neuroprotection, modulates the immune response, and improves cognitive function.
Cerebrolysin
Dosage: 10 ml IV, five days a week for 4 weeks.
Function: A mixture of neuropeptides that supports neuroplasticity, neuroprotection, and cognitive function.
NAD+ (Nicotinamide Adenine Dinucleotide) IV Therapy
Dosage: 500 mg intravenously, three times a week.
Function: Supports mitochondrial function and energy production, crucial for brain health and repair.
Duration of Use and Timeline of Results:
Initial Phase (Weeks 1-4):
DNSP-11: Twice a week subcutaneous injections to promote dopamine neuron health.
Tesofensine: Daily oral intake to increase neurotransmitter levels.
P5P: Daily oral intake to support neurotransmitter synthesis.
NA-Semax: Twice a day intranasal administration to enhance cognitive function.
Cerebrolysin: Daily intramuscular injections for five days a week to boost neuroplasticity and repair.
Maintenance Phase (Months 2-3):
DNSP-11: Continue twice a week for sustained neuroprotection.
Tesofensine: Continue daily to maintain elevated neurotransmitter levels.
P5P: Continue daily to support ongoing neurotransmitter synthesis.
NA-Semax: Continue twice a day to sustain cognitive enhancement.
NMN IV Therapy: Twice a month changing to once a month after 3 months to support overall brain health and repair.
Assessment and Adjustment (Months 4+):
Evaluate cognitive function, mood, and neuroimaging results.
Adjust dosages or components based on individual response and side effects.
Consider reducing the frequency of NAD+ IV therapy to once a week for maintenance.
Potential continuation of P5P, NA-Semax, and Tesofensine based on long-term goals.
Expected Outcomes:
Week 1-2: Initial improvement in cognitive clarity and energy levels. Possible reduction in brain fog and enhanced mood.
Week 3-4: Noticeable improvements in cognitive function, memory, and attention span. Reduced symptoms of neurodegeneration and better stress response.
Month 2-3: Sustained cognitive enhancement, increased resilience to stress, and improved overall brain health. Ongoing repair of neurodamage and neurogenesis.
Month 4+: Long-term stabilization of cognitive functions, with possible further improvements in brain structure and function based on neuroimaging assessments.
Safety and Monitoring:
Regular monitoring of cognitive function and mood.
Neuroimaging (MRI, PET scans) to assess brain structure and function improvements.
Blood tests to monitor neurotransmitter levels and overall metabolic health.
Adjustment of dosages based on individual response and potential side effects.
This protocol combines cutting-edge peptides, research compounds, and essential cofactors to provide a comprehensive approach to enhancing dopamine and norepinephrine function and repairing brain areas affected by modern lifestyle factors.